(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) jumped 8.59% to $17.82 at 11:43 EST on Wednesday, following the last session’s upward trend. NASDAQ is jumping 0.62% to $11,138.45, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat up trend exchanging session today.
Castle Biosciences’s last close was $16.41, 79.21% under its 52-week high of $78.92.
Today’s last reported volume for Castle Biosciences is 94420 which is 75.8% below its average volume of 390170.
The company’s growth estimates for the present quarter and the next is a negative 114.3% and a negative 68.1%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.14%, a negative 0.72%, and a positive 5.07%, respectively.
Castle Biosciences’s highest amplitude of average volatility was 2.85% (last week), 4.52% (last month), and 5.07% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be oversold (<=20).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $17.82 at 11:43 EST, way below its 52-week high of $78.92 and higher than its 52-week low of $17.01.
Castle Biosciences’s Moving Average
Castle Biosciences’s worth is way below its 50-day moving average of $24.61 and way below its 200-day moving average of $44.68.
More news about Castle Biosciences (CSTL).